Generation of CD34(+)CD43(+) Hematopoietic Progenitors to Induce Thymocytes from Human Pluripotent Stem Cells

Immunotherapy using primary T cells has revolutionized medical care in some pathologies in recent years, but limitations associated to challenging cell genome edition, insufficient cell number production, the use of only autologous cells, and the lack of product standardization have limited its clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Flippe, Léa, Gaignerie, Anne, Sérazin, Céline, Baron, Olivier, Saulquin, Xavier, Anegon, Ignacio, David, Laurent, Guillonneau, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777438/
https://www.ncbi.nlm.nih.gov/pubmed/36552810
http://dx.doi.org/10.3390/cells11244046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777438/
https://www.ncbi.nlm.nih.gov/pubmed/36552810
http://dx.doi.org/10.3390/cells11244046

Ejemplares similares